作者：
Stéphane,Chevaliez [1]
;
Francesco,Onelia [2]
;
Monia,Pacenti [3]
;
Emily,Goldstein [4]
;
Juan-Carlos,Galán [5]
;
Laura,Martínez-García [5]
;
Alba,Vilas [6]
;
Allison,Glass [7]
;
Leana,Maree [7]
;
Maria,Krügel [7]
;
Robert,Ehret [8]
;
Heribert,Knechten [9]
;
Patrick,Braun [9]
;
Gudrun,Naeth [9]
;
Sara,Bonanzinga [10]
;
Kathy,Jackson [10]
;
Klara,Abravaya [11]
;
Jens,Dhein [12]
;
Shihai,Huang [11]
;
Ajith M,Joseph [11]
;
Danijela,Lucic [11]
;
Natalia,Marlowe [11]
;
Michael J,Palm [11]
;
Karin,Pfeifer [12]
;
Dan,Toolsie [11]
;
Birgit,Reinhardt [12]
;
Martin,Obermeier [8]
;
Rory,Gunson [4]
作者单位：
National Reference Center for Viral Hepatitis B, C, and D, Department of Virology, Hôpital Henri Mondor, Université Paris-Est, Créteil, France; INSERM U955, Créteil, France. Electronic address: stephane.chevaliez@aphp.fr.
[1]
Università di Padova, Padua, Italy.
[2]
Azienda Ospedaliera di Padova, Padua, Italy.
[3]
West of Scotland Specialist Virology Centre, Glasgow, UK.
[4]
Servicio de Microbiología. Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS) and CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
[5]
Laboratori de Referència de Catalunya, El Prat de Llobregat, Spain.
[6]
Lancet Laboratories, Johannesburg, South Africa.
[7]
Medizinisches Infektiologiezentrum Berlin, Germany.
[8]
Laboratory Dr. Knechten, Medical Center for HIV and Hepatitis, Aachen, Germany.
[9]
Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Victoria, 3000, Australia.
[10]
Abbott Molecular, Des Plaines, IL, USA.
[11]
Abbott GmbH, Wiesbaden, Germany.
[12]
DOI
10.1016/j.jcv.2020.104531
PMID
32688330
发布时间
2021-08-20
换一批
换一批
